Valued at USD 7.95 billion in 2025, the microbiology testing market is projected to reach USD 8.21 billion in 2026 and USD 10.81 billion by 2034, growing at a CAGR of 5.5% during the forecast period 2026–2034. Expansion is supported by the rising prevalence of infectious diseases, increasing hospital-acquired infections, and growing demand for regulatory-compliant testing across healthcare and industrial sectors. Key players profiled by Polaris Market Research include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Beckman Coulter, Bio-Rad Laboratories, bioMérieux SA, Bruker Corporation, Charles River Laboratories International, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Hologic, Merck KGaA, Neogen Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc.

Infectious Disease Testing Drives Diagnostic Demand

Increasing cases of infectious diseases are boosting the microbiology testing market. According to the World Health Organization, tuberculosis accounted for 1.23 million deaths in 2024, making it one of the leading causes of death from a single infectious agent. This is strengthening infectious disease testing, and hospitals and laboratories are enhancing their capabilities to handle the patient load. The trend also supports pharmaceutical and food microbiology, where testing is a critical aspect of compliance and quality control.

Hospital-Acquired Infections Strengthen Routine Monitoring

Rising hospital-acquired infections are increasing the need for screening and infection control. ICU environments, surgical units, and long-term care facilities require constant monitoring for microbial infections to prevent their spread. A study in the Journal of the Association of Physicians of India reported an incidence rate of 4.4% for these infections, equal to 9.06 infections per 1,000 ICU-days. Such figures reinforce demand for microbiology testing in hospitals and support routine microbial monitoring and rapid diagnostics. Intensive care, surgical, and long-term care settings therefore sit at the center of demand for microbial monitoring.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/microbiology-testing-market

Culture-Based Methods Retain Leadership

By technology, culture-based methods held around 36% of the market in 2025, supported by regulatory acceptance and high reliability in diagnostic applications. These traditional approaches are commonly applied in pharmaceutical and food safety testing. The report lists high accuracy and regulatory acceptance as their key advantages, with longer turnaround time as the main limitation, which explains growing interest in faster alternatives.

Molecular Diagnostics and Clinical Applications

Molecular diagnostics and PCR testing are expected to grow at a CAGR of approximately 10.5% during the forecast period, making them the fastest-growing technology segment. They provide precise identification of infectious pathogens in a shorter time frame, although higher cost and infrastructure needs remain limitations. Clinical microbiology testing is the largest application, capturing nearly 40% of the market in 2025 on the high volume of patient testing, while hospitals and diagnostic laboratories led end users with about 44% share, reflecting their established infrastructure and widespread testing capabilities.

Market Scope and Regulated Industries

The market covers the detection, identification, and analysis of bacteria, viruses, fungi, and parasites, including sample collection, testing, analysis, and results generation. Its scope includes incubators and PCR systems, reagents, consumables, test kits, and services. Major applications include pharmaceutical sterility testing, food contaminant testing, and hospital testing, where accurate identification of microorganisms is crucial, and the report identifies the process as the core of microbiological testing in regulated industries.

Application and End-User Segmentation

By application, the market spans pharmaceutical, food, clinical diagnostics, and environmental testing. By end user, it covers hospitals and diagnostic laboratories, pharma and biotech companies, the food and beverage industry, and CROs and research institutes. Pharma and biotech is the fastest-growing end-user group.

Regional Outlook for the Microbiology Testing Market

North America dominated with about 37% share in 2025, driven by well-established laboratory infrastructure and strong adoption of automated systems. Asia Pacific recorded the fastest growth on rising healthcare expenditure and expanding pharmaceutical manufacturing in China and India, while Europe was the second-largest market, shaped by stringent regulatory requirements. High initial costs of advanced systems remain a restraint for smaller laboratories, yet the microbiology testing market is projected to reach USD 10.81 billion by 2034.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market